Cti Biopharma reported $0 in Loan Capital for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Applied Genetic Technologies AGTC:US $ 15.66M 2.07M
Baxter International BAX:US $ 5446M 264M
Bristol Myers Squibb BMY:US $ 39677M 2826M
Cti Biopharma CTIC:US $ 0M 0M
Cytori Therapeutics CYTX:US $ 0 0
Eli Lilly And LLY:US $ 15522.4M 785.8M
Geron GERN:US $ 34.67M 0.25M
Mirati Therapeutics MRTX:US $ 0M 0M
Northwest Biotherapeutics NWBO:US 12.34M 53K
Novartis NOVN:VX SF 24715M 1776M
Novartis NVS:US $ 24715M 1776M
Seattle Genetics SGEN:US $ 0M 0M
Sunesis Pharmaceuticals SNSS:US $ 5.03M 0.87M
Teva Pharmaceutical Industries TEVA:US $ 21037M 565M
YTE INCY:US $ 31.38M 0.46M